Illumina Lays off More Than 300 Employees
The company has reduced its head count by approximately 5 percent so far this year and has laid off approximately 1,000 employees since late 2022.
NIH Funding Cut by 40 Percent in Trump Admin's FY2026 Budget Proposal
The proposal also details the administration's plan to eliminate four NIH institutes or centers while combining the remaining 23 into a total of eight.
ESCMID Presenters Make Case for Clinical Implementation of Metagenomics for Infectious Disease Dx
Premium
In a session at the conference, multiple researchers presented data on their implementation of metagenomic sequencing for diagnostic use cases.
GeneDx to Acquire Fabric Genomics in Deal Potentially Worth $51M
The acquisition is expected to close in Q2, and GeneDx could pay up to $51 million for Fabric upon achievement of certain milestones.
Bruker Makes Majority Investment in Mass Spec Dx Firm
Bruker said the investment will increase its capabilities in small molecule clinical diagnostics, including in therapeutic drug monitoring and other applications.
Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test
The company's tumor genotyping test will now be reimbursed for eligible Medicare patients under Palmetto GBA's local coverage determination for this class of assays.
Parasitic Infection, Treatment Could Have Ties to Cervical Cancer, Researchers Report at ESCMID
Premium
The findings point to a potential role for infection with Schistosoma haematobium parasites — and, surprisingly, for their only effective treatment — in cervical cancer.
Illumina, Tempus AI Collaborate on Generating Evidence for Clinical NGS-Based Testing
The companies plan to combine Tempus' multimodal data platform and Illumina's AI-driven molecular analysis technologies.